Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sangamo Therapeutics (SGMO) Asset Utilization Ratio (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.53 as the latest value for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio changed 0.0% year-over-year to 0.53; the TTM value through Dec 2025 reached 0.53, changed 0.0%, while the annual FY2025 figure was 0.49, 13.2% up from the prior year.
  • Asset Utilization Ratio hit 0.53 in Q4 2025 for Sangamo Therapeutics, up from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.92 in Q4 2023 and bottomed at 0.11 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 0.38, with a median of 0.27 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio crashed 80.62% in 2024 and then skyrocketed 693.74% in 2025.
  • Sangamo Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then surged by 73.87% to 0.19 in 2022, then skyrocketed by 375.59% to 0.92 in 2023, then plummeted by 41.77% to 0.53 in 2024, then dropped by 0.0% to 0.53 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.53, 0.34, and 0.88 for Q4 2025, Q3 2025, and Q2 2025 respectively.